ロード中...
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Epratuzumab has demonstrated therapeutic activity in patients with non-Hodgkin lymphoma, acute lymphoblastic leukemia, systemic lupus erythematosus, and Sjögren's syndrome, but its mechanism of affecting normal and malignant B cells remains incompletely understood. We reported previously that e...
保存先:
| 出版年: | MAbs |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622945/ https://ncbi.nlm.nih.gov/pubmed/25484043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.979081 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|